May 12, 2021 Lab Top-10 Licensing, IP, and Legal M&A, Partnerships PAI Top-10

PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing WALTHAM, Mass.–(BUSINESS WIRE)–May 12, 2021– PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close... Read more

May 11, 2021 Clinical Research/Diagn. PAI Top-10 Product Launch

Roche to present data from one of the most comprehensive oncology portfolios at the 2021 ASCO Annual Meeting showcasing advancements for people living with cancer

Data from the first positive phase III study of a cancer immunotherapy in early, resected lung cancer Studies in personalised healthcare exploring tumour agnostic treatments that demonstrate the impact of coupling biomarker testing with targeted therapies to develop individualised treatment plans New data, and drug combination strategies for the treatment of lymphoma from the largest... Read more

May 10, 2021 Atomic Spectroscopy Liq. Handling & Robotics PAI Top-10 PR/Corporate

Brooks Automation Reports Results of Second Quarter of Fiscal 2021, Ended March 31, 2021, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of Second Quarter of Fiscal 2021, Ended March 31, 2021, and Announces Quarterly Cash Dividend Record Revenue and Continued Margin Expansion in Both Life Sciences and Semiconductor Solutions CHELMSFORD, Mass., May 10, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the second fiscal quarter of 2021,... Read more

May 6, 2021 PAI Top-10

BD Announces Second Fiscal Quarter Results; Reaffirms Fiscal 2021 Guidance

FRANKLIN LAKES, N.J., May 6, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.9 billion for the second fiscal quarter ended March 31, 2021.  This represents an increase of 15.4% over the prior-year period on a reported basis and was driven by the contribution of... Read more

May 5, 2021 PAI Top-10

Thin Film Fracture Toughness and Focused Ion Beam (FIB) Milling

Dr. Benoit Merle is a group leader and faculty member with the University of Erlangen-Nuremberg in the Department of Materials Science and Engineering. He is a lecturer, mentor to graduate students and manages the nanomechanical research lab. We interviewed Dr. Merle about his recent publication, which investigated focused ion beam (FIB) milling and fracture toughness... Read more

May 5, 2021 Lab Top-10 PAI Top-10 PR/Corporate

Bruker Reports First Quarter 2021 Financial Results

Q1 2021 revenue growth of 30.8% year-over-year, organic revenue growth of 23.8% Q1 2021 GAAP EPS of $0.37; non-GAAP EPS of $0.44, compared to $0.14 in Q1 2020 Raising fiscal year 2021 outlook on strong demand for the Company’s high-performance life science tools, scientific instruments and diagnostic solutions BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR)... Read more

May 4, 2021 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

PerkinElmer Announces Financial Results for the First Quarter of 2021

Revenue of $1.308 billion; 100% reported growth; 92% organic growth GAAP EPS from continuing operations of $3.37; Adjusted EPS of $3.72 Initiates Second Quarter and Raises Full-Year Revenue and Earnings Guidance WALTHAM, Mass.–(BUSINESS WIRE)–May 4, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for... Read more

May 4, 2021 PAI Top-10 PR/Corporate

Xylem Reports First Quarter 2021 Results

Revenue growth 12% on a reported basis, 8% organically Double-digit orders growth across all business segments, reflecting strong commercial momentum and underlying demand in critical infrastructure Adjusted EBITDA margin of 17.1%, up 480 basis points; net income as a percentage of revenue was 6.9%, up 350 basis points Reported net income of $87 million or... Read more

April 29, 2021 Environ, Ag./Food & Bev PAI Top-10

Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that it has filed an action in the General Court of the European Union asking for annulment of the European Commission’s decision asserting jurisdiction to review Illumina’s acquisition of GRAIL. The Commission asserted jurisdiction to review the acquisition under Article 22 of the EU Merger Regulation on... Read more